• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of correspondence responded to within the month

Dictionary: The Office of the Center Director is responsible for answering the public's and Congress’ questions about the work done by FDA/CVM. This measure tracks the Office of the Center Director’s timeliness in completing referrals as tracked by the AIMS system and Office of Legislation which are related to all Congressional correspondence. Congressional correspondences include: general information requests, constituent related requests, letters expressing concerns from Congress, questions for the record related to hearings, briefing requests, technical and document requests.

The Office of the Center Director is responsible for answering the public's questions about the work done by FDA/CVM. This measure tracks the Office of the Center Director’s timeliness in completing referrals related to all non-Congressional correspondence. Non-Congressional letter correspondences include: public inquiries received by the Secretary, Commissioner, and Center Director regarding: general information requests, expertise of a specific subject/issue, pre and post approvals, hot topic items, and any other CVM related issues.

Information is current as of March 31, 2014.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 201195100
Nov 201195100
Dec 201195100
Jan 201295100
Feb 201295100
Mar 201295100
Apr 201295100
May 201295100
Jun 201295100
Jul 201295100
Aug 201295100
Sep 201295100

FY 2012 Overall: 100

Total number of correspondence received within the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A19
Nov 2011N/A20
Dec 2011N/A20
Jan 2012N/A34
Feb 2012N/A38
Mar 2012N/A13
Apr 2012N/A23
May 2012N/A19
Jun 2012N/A33
Jul 2012N/A32
Aug 2012N/A12
Sep 2012N/A18

FY 2012 Total: 281

Total number of correspondence responded to within the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A19
Nov 2011N/A20
Dec 2011N/A20
Jan 2012N/A34
Feb 2012N/A38
Mar 2012N/A13
Apr 2012N/A23
May 2012N/A19
Jun 2012N/A33
Jul 2012N/A32
Aug 2012N/A12
Sep 2012N/A18

FY 2012 Total: 281

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.